Nitrosamine impurities in medications: Recalls 

On this page

What you should do

If a drug is recalled, you shouldn't stop taking your prescription medications until you:

Going without treatment for a medical condition may pose a greater health risk than potential nitrosamine exposure.

Speak to your pharmacist to see if the lot of medication you're taking is part of the recall.

You're encouraged to report a side effect to a drug or complaint to Health Canada.

ARBs recalls

Sartans or angiotensin II receptor blockers (ARBs)

If you're taking an ARB that has been recalled, you should:

Some ARBs have been recalled due to the presence of, or potential for, nitrosamine impurities.

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not affect Canadian products.

List of ARB medications recalled in Canada
Product name DIN Strength Lot # Date recalled API manufacturer
AURO-IRBESARTAN/HCT 02447878 150/12.5 mg IN1518001-A April 17, 2019 Aurobindo Pharma Limited, Unit-I
IRBESARTAN (PRO DOC LIMITEE) 02365200 150 mg 604292 March 11, 2019 TEVA API India Ltd.
IRBESARTAN (PRO DOC LIMITEE) 02365219 300 mg 601795 March 11, 2019 TEVA API India Ltd.
APO-LOSARTAN 02379058 25 mg NL1453 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02379058 25 mg NL1452 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02353504 50 mg NK1254 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02353504 50 mg NK1253 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02353512 100 mg NL1461 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02353512 100 mg NG2092 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02353512 1 00 mg NH5932 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02353512 100 mg NH5933 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02353512 100 mg NL1460 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN 02353512 100 mg NH5934 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371235 50/12.5 mg NL1441 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371235 50/12.5 mg NZ8848 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371235 50/12.5 mg NL1445 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371235 50/12.5 mg NZ8849 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371235 50/12.5 mg NZ8860 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371243 100/12.5 mg NG2087 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371243 100/12.5 mg NL1421 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371243 100/12.5 mg NG2086 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371243 100/12.5 mg NL1422 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371251 100/25 mg NL1429 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371251 100/25 mg NZ8846 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371251 100/25 mg NZ8847 March 8, 2019 Hetero Laboratories Limited Unit 1
APO-LOSARTAN/HCTZ 02371251 100/25 mg NZ8845 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309750 25 mg 498294 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309750 25 mg 605342 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309750 25 mg 611944 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309769 50 mg 498285 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309769 50 mg 600047 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309769 50 mg 600091 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309769 50 mg 603894 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309769 50 mg 612025 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309769 50 mg 612031 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309769 50 mg 612679 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309769 50 mg 616743 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309777 100 mg 498864 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309777 100 mg 602668 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309777 100 mg 603816 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309777 100 mg 605298 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309777 100 mg 605300 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309777 100 mg 613935 March 8, 2019 Hetero Laboratories Limited Unit 1
PMS-LOSARTAN 02309777 100 mg 613936 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394367 25 mg 498292 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394367 25 mg 605344 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394375 50 mg 498779 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394375 50 mg 600046 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394375 50 mg 603903 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394375 50 mg 498284 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394375 50 mg 603895 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394383 100 mg 499008 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394383 100 mg 605299 March 8, 2019 Hetero Laboratories Limited Unit 1
LOSARTAN (PRO DOC LIMITEE) 02394383 100 mg 605297 March 8, 2019 Hetero Laboratories Limited Unit 1
TEVA-LOSARTAN/HCTZ 02358263 50/12.5 mg 35344801A March 6, 2019 Hetero Laboratories Limited Unit 1
TEVA-LOSARTAN/HCTZ 02358263 50/12.5mg 35349397A March 6, 2019 Hetero Laboratories Limited Unit 1
MYLAN-VALSARTAN 02383527 40 mg All lots November 28, 2018 Mylan Laboratories Limited
MYLAN-VALSARTAN 02383535 80 mg All lots November 28, 2018 Mylan Laboratories Limited
MYLAN-VALSARTAN 02383543 160 mg All lots November 28, 2018 Mylan Laboratories Limited
MYLAN-VALSARTAN 02383551 3 20 mg All lots November 28, 2018 Mylan Laboratories Limited
TEVA-VALSARTAN/HCTZ TABLETS 02356996 80/12.5 mg 35211136A August 17, 2018 Zhejiang Huahai Pharmaceuticals
TEVA-VALSARTAN/HCTZ TABLETS 02357003 160/12.5 mg 35211335A August 17, 2018 Zhejiang Huahai Pharmaceuticals
TEVA-VALSARTAN/HCTZ TABLETS 02357003 160/12.5 mg 35211844R August 17, 2018 Zhejiang Huahai Pharmaceuticals
TEVA-VALSARTAN/HCTZ TABLETS 02357011 160/25 mg 35210937R August 17, 2018 Zhejiang Huahai Pharmaceuticals
TEVA-VALSARTAN/HCTZ TABLETS 02357011 160/25 mg 35210938R August 17, 2018 Zhejiang Huahai Pharmaceuticals
TEVA-VALSARTAN/HCTZ TABLETS 02357011 160/25 mg 35210939R August 17, 2018 Zhejiang Huahai Pharmaceuticals
TEVA-VALSARTAN/HCTZ TABLETS 02357011 160/25 mg 35210940R August 17, 2018 Zhejiang Huahai Pharmaceuticals
TEVA-VALSARTAN/HCTZ TABLETS 02357038 3 20/12.5 mg 35211546R August 17, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337487 40 mg K47338 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337495 80 mg K45370 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337495 80 mg K47652 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337495 80 mg K47653 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337495 80mg K47654 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337509 160 mg K39691 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337509 160 mg K44167 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337509 160 mg K47657 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337509 160 mg K47658 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337517 320 mg K44166 July 9, 2018 Zhejiang Huahai Pharmaceuticals
ACT-VALSARTAN 02337517 320 mg K45371 July 9, 2018 Zhejiang Huahai Pharmaceuticals
VALSARTAN (PRO DOC LIMITEE) 02367726 40 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
VALSARTAN (PRO DOC LIMITEE) 02367734 80 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
VALSARTAN (PRO DOC LIMITEE) 02367742 160 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
VALSARTAN (PRO DOC LIMITEE) 02367750 320 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
SANDOZ VALSARTAN 02356740 40 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
SANDOZ VALSARTAN 02356759 80 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
SANDOZ VALSARTAN 02356767 160 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
SANDOZ VALSARTAN 02356775 320 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
SANIS VALSARTAN 02366940 40 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
SANIS VALSARTAN 02366959 80 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
SANIS VALSARTAN 02366967 160 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
SANIS VALSARTAN 02366975 320 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
VALSARTAN (SIVEM PHARMACEUTICAL ULC) 02384523 40 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
VALSARTAN (SIVEM PHARMACEUTICAL ULC) 02384531 80 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
VALSARTAN (SIVEM PHARMACEUTICAL ULC) 02384558 160 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
VALSARTAN (SIVEM PHARMACEUTICAL ULC) 02384566 320 mg All lots July 9, 2018 Zhejiang Huahai Pharmaceuticals
TEVA-VALSARTAN/HCTZ 02357046 320/25 mg 35212731R July 9, 2018 Zhejiang Huahai Pharmaceuticals

 

Communications related to ARB recalls:

Ranitidine recalls

Ranitidine

If you're taking a ranitidine product, you should:

Some ranitidine products have been recalled due to the presence of or potential for nitrosamine impurities

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not affect Canadian products.

The following ranitidine products have been recalled in Canada.

List of ranitidine products in Canada that have been recalled
Company Product name DIN Strength Lot Date added
Pharmascience Inc. ATOMA maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 629744F 2022-03-11
Pharmascience Inc. ATOMA maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632058H 2022-03-11
Pharmascience Inc. Compliments maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632043B 2022-03-11
Pharmascience Inc. Compliments maximum strength acid reducer without prescription cool mint (24 tablets) 02293471 150 mg 629973A 2022-03-11
Pharmascience Inc. CO-OP Care+ maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 629744C 2022-03-11
Pharmascience Inc. Health One maximum strength acid reducer without prescription (32 tablets) 02293471 150 mg 629744J 2022-03-11
Pharmascience Inc. Health One maximum strength acid reducer without prescription (32 tablets) 02293471 150 mg 632043H 2022-03-11
Pharmascience Inc. Life Brand maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 629744H 2022-03-11
Pharmascience Inc. Life Brand maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632058I 2022-03-11
Pharmascience Inc. Life Brand maximum strength acid reducer without prescription cool mint (48 tablets) 02293471 150 mg 629974B 2022-03-11
Pharmascience Inc. Life Brand maximum strength acid reducer without prescription cool mint (24 tablets) 02293471 150 mg 629974A 2022-03-11
Pharmascience Inc. Option+ maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 629744G 2022-03-11
Pharmascience Inc. Option+ maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632043D 2022-03-11
Pharmascience Inc. Option+ maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632043E 2022-03-11
Pharmascience Inc. Option+ maximum strength acid reducer without prescription (8 tablets) 02293471 150 mg 632058A 2022-03-11
Pharmascience Inc. Option+ maximum strength acid reducer without prescription cool mint (24 tablets) 02293471 150 mg 629973B 2022-03-11
Pharmascience Inc. Option+ maximum strength acid reducer without prescription cool mint (24 tablets) 02293471 150 mg 631893C 2022-03-11
Pharmascience Inc. PERSONNELLE maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 629744E 2022-03-11
Pharmascience Inc. PERSONNELLE maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632043A 2022-03-11
Pharmascience Inc. PERSONNELLE maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632043F 2022-03-11
Pharmascience Inc. PERSONNELLE maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632058J 2022-03-11
Pharmascience Inc. PERSONNELLE maximum strength acid reducer without prescription (8 tablets) 02293471 150 mg 629744B 2022-03-11
Pharmascience Inc. PERSONNELLE maximum strength acid reducer without prescription (8 tablets) 02293471 150 mg 632058B 2022-03-11
Pharmascience Inc. PERSONNELLE maximum strength acid reducer without prescription cool mint (24 tablets) 02293471 150 mg 629973C 2022-03-11
Pharmascience Inc. PERSONNELLE maximum strength acid reducer without prescription cool mint (48 tablets) 02293471 150 mg 629973D 2022-03-11
Pharmascience Inc. PHARMASAVE maximum strength acid reducer without prescription (8 tablets) 02293471 150 mg 629744A 2022-03-11
Pharmascience Inc. Rexall maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 629744I 2022-03-11
Pharmascience Inc. Rexall maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632043G 2022-03-11
Pharmascience Inc. Rexall maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 632058G 2022-03-11
Pharmascience Inc. Rexall maximum strength acid reducer without prescription (8 tablets) 02293471 150 mg 632058D 2022-03-11
Pharmascience Inc. BIOMEDIC Acid Reducer (30 tablets) 02247551 75 mg 632952I 2021-12-03
Pharmascience Inc. Life Brand Acid Reducer (30 tablets) 02247551 75 mg 632952K 2021-12-03
Pharmascience Inc. OPTION+ Acid Reducer (10 tablets) 02247551 75 mg 632952B 2021-12-03
Pharmascience Inc. OPTION+ Acid Reducer (40 tablets) 02247551 75 mg 633694B 2021-12-03
Pharmascience Inc. Personnelle Acid Reducer (10 tablets) 02247551 75 mg 632952D 2021-12-03
Pharmascience Inc. ATOMA maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 627765H 2021-12-03
Pharmascience Inc. BIOMEDIC maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 627765I 2021-12-03
Pharmascience Inc. BIOMEDIC maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 628471C 2021-12-03
Pharmascience Inc. Compliments maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 628471D 2021-12-03
Pharmascience Inc. CO-OP Care+ maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 627765D 2021-12-03
Pharmascience Inc. Health One maximum strength acid reducer without prescription (32 tablets) 02293471 150 mg 628471A 2021-12-03
Pharmascience Inc. London Drugs maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 627765E 2021-12-03
Pharmascience Inc. Option+ maximum strength acid reducer without prescription (8 tablets) 02293471 150 mg 627765B 2021-12-03
Pharmascience Inc. Option+ maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 627765G 2021-12-03
Pharmascience Inc. PHARMASAVE maximum strength acid reducer without prescription (8 tablets) 02293471 150 mg 627765C 2021-12-03
Pharmascience Inc. PHARMASAVE maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 628471B 2021-12-03
Pharmascience Inc. Rexall maximum strength acid reducer without prescription (8 tablets) 02293471 150 mg 627765A 2021-12-03
Pharmascience Inc. Rexall maximum strength acid reducer without prescription (24 tablets) 02293471 150 mg 627765F 2021-12-03
Pharmascience Inc. Compliments Maximum Strength Acid Reducer (50 tablets) 02293471 150mg 628453 2021-02-05
Pharmascience Inc. CO-OP CARE + Maximum Strength Acid Reducer (24 tablets) 02293471 150mg 628308F 2021-02-05
Pharmascience Inc. Life Brand Maximum Strength Acid Reducer (50 tablets) 02293471 150mg 628429 2021-02-05
Pharmascience Inc. Life Brand Maximum Strength Acid Reducer (24 tablets) 02293471 150mg 628308E 2021-02-05
Pharmascience Inc. Option+ Maximum Strength Acid Reducer (8 tablets) 02293471 150mg 628308B 2021-02-05
Pharmascience Inc. Personnelle Maximum Strength Acid Reducer (50 tablets) 02293471 150mg 628442 2021-02-05
Pharmascience Inc. PERSONNEL Maximum Strength Acid Reducer (8 tablets) 02293471 150mg 628308A
628308C
2021-02-05
Pharmascience Inc. PERSONNEL Maximum Strength Acid Reducer (24 tablets) 02293471 150mg 628308D 2021-02-05
Pharmascience Inc. pms-RANITIDINE 02242453 150mg 626718
623633
624871
626714
2021-02-05
Pharmascience Inc. ATOMA Acid Reducer (10 tablets) 02247551 75 mg 621791O 2021-01-30
Pharmascience Inc. ATOMA Acid Reducer (30 tablets) 02247551 75 mg 621791X 2021-01-30
Pharmascience Inc. BIOMEDIC Acid Reducer (30 tablets) 02247551 75 mg 621791K 2021-01-30
Pharmascience Inc. BIOMEDIC Acid Reducer (30 tablets) 02247551 75 mg 621791U 2021-01-30
Pharmascience Inc. Compliments Acid Reducer (60 tablets) 02247551 75 mg 621791D 2021-01-30
Pharmascience Inc. Life Brand Acid Reducer (10 tablets) 02247551 75 mg 621791G 2021-01-30
Pharmascience Inc. Life Brand Acid Reducer (10 tablets) 02247551 75 mg 621791P 2021-01-30
Pharmascience Inc. Life Brand Acid Reducer (30 tablets) 02247551 75 mg 621791Q 2021-01-30
Pharmascience Inc. Life Brand Acid Reducer (60 tablets) 02247551 75 mg 621791AA 2021-01-30
Pharmascience Inc. London Drugs Acid Reducer (30 tablets) 02247551 75 mg 621791R 2021-01-30
Pharmascience Inc. OPTION+ Acid Reducer (10 tablets) 02247551 75 mg 621791H 2021-01-30
Pharmascience Inc. OPTION+ Acid Reducer (10 tablets) 02247551 75 mg 621791T 2021-01-30
Pharmascience Inc. OPTION+ Acid Reducer (40 tablets) 02247551 75 mg 621791Y 2021-01-30
Pharmascience Inc. Personnelle Acid Reducer (10 tablets) 02247551 75 mg 621791A 2021-01-30
Pharmascience Inc. Personnelle Acid Reducer (10 tablets) 02247551 75 mg 621791N 2021-01-30
Pharmascience Inc. Personnelle Acid Reducer (40 tablets) 02247551 75 mg 621791I 2021-01-30
Pharmascience Inc. Personnelle Acid Reducer (40 tablets) 02247551 75 mg 621791Z 2021-01-30
Pharmascience Inc. PHARMASAVE Acid Reducer (30 tablets) 02247551 75 mg 621791V 2021-01-30
Pharmascience Inc. Rexall Acid Reducer (60 tablets) 02247551 75 mg 621791S 2021-01-30
Pharmascience Inc. Rexall Acid Reducer (10 tablets) 02247551 75 mg 621791F 2021-01-30
Pharmascience Inc. Rexall Acid Reducer (10 tablets) 02247551 75 mg 621791M 2021-01-30
Pharmascience Inc. Rexall Acid Reducer (30 tablets) 02247551 75 mg 621791E 2021-01-30
Pharmascience Inc. Rexall Acid Reducer (30 tablets) 02247551 75 mg 621791W 2021-01-30
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name Compliments 02247551 75 mg 619254I 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name EXACT 02247551 75 mg 619254G 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name EXACT 02247551 75 mg 619254B 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name Life Brand 02247551 75 mg 624735C 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name Life Brand 02247551 75 mg 627539C 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name Life Brand 02247551 75 mg 619254H 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name Life Brand 02247551 75 mg 619254C 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name OPTION+ 02247551 75 mg 624735B 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name OPTION+ 02247551 75 mg 627539B 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name Personnelle 02247551 75 mg 624735A 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name Personnelle 02247551 75 mg 619254K 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name Personnelle 02247551 75 mg 627539A 2021-01-08
Pharmascience Inc. Acid Reducer (raniditine) sold under the brand name PHARMASAVE 02247551 75 mg 619254J 2021-01-08
Pharmascience Inc. PMS-Ranitidine 150 mg 02242453 150 mg 619003 2020-08-31
Ranbaxy Pharmaceuticals Canada Inc. Ran-Ranitidine 02336480 150 mg All lots 2019-10-30
Ranbaxy Pharmaceuticals Canada Inc. Ran-Ranitidine 02336502 300 mg All lots 2019-10-30
Dominion Pharmacal Maximum Strength Acid Reducer Without Prescription (ranitidine) sold under the brand name Personnelle 02407523 150 mg All lots 2019-10-25
Laboratoire Riva Inc. Riva-Ranitidine 150 02247814 150 mg All lots 2019-10-25
Laboratoire Riva Inc. Riva-Ranitidine 300 02247815 300 mg All lots 2019-10-25
Laboratoire Riva Inc. Acid Reducer (ranitidine) sold under the brand names Biomedic, Circle K and Option+ 02452464 75 mg All lots 2019-10-25
Pharmascience Inc. PMS-Ranitidine 150 mg 02242453 150 mg All lots 2019-10-25
Pharmascience Inc. PMS-Ranitidine 300 mg 02242454 300 mg Al lots 2019-10-25
Pharmascience Inc. Acid Reducer (ranitidine) sold under the brand names Atoma, Biomedic, Compliments, Exact, Life Brand, London Drugs, Option+, Personnelle, Pharmasave, Preferred Pharmacy, Rexall and Selection 02247551 75 mg All lots 2019-10-25
Pharmascience Inc. Maximum Strength Acid Reducer Without Prescription (ranitidine) sold under the brand names Atoma, Biomedic, Compliments, Co-op Care+, Equate, Exact, Health One, Kirkland Signature, London Drugs, Option+, Personnelle, Pharmasave, Rexall and Selection 02293471 150 mg All lots 2019-10-25
Pharmascience Inc. Acid Reducer (ranitidine) sold under the brand names Exact and Life Brand 02400103 150 mg All lots 2019-10-25
Vita Health Products Inc. Acid Reducer (ranitidine) sold under the brand names Equate, iPharma, Stanley and Western Family 02298740 75 mg All lots 2019-10-25
Vita Health Products Inc. Maximum Strength Acid Reducer (ranitidine) sold under the brand names Equate, iPharma and Western Family 02298902 150 mg All lots 2019-10-25
Sanofi Consumer Health Inc. Zantac (ranitidine) 02230287 75 mg All lots 2019-10-18
Sanofi Consumer Health Inc. Zantac Maximum Strength Non-Prescription (ranitidine) 02277301 150 mg All lots 2019-10-18
Sivem Pharmaceuticals ULC Ranitidine 02385953 150 mg K46484
K46485
K48440
K48679
K50204
K50206
K50207
K50590
K50594
K50677
K50908
K50925
K50928
K50932
K50935
K51080
2019-10-18
Sivem Pharmaceuticals ULC Ranitidine 02385961 300 mg K50624
K50941
K50947
K50950
2019-10-18
Teva Canada Limited Act Ranitidine 02248570 150 mg All lots 2019-10-18
Teva Canada Limited Act Ranitidine 02248571 300 mg All lots 2019-10-18
Apotex Inc. Acid Reducer (ranitidine) sold under the brand names Equate and Selection 02296160 150 mg All lots 2019-09-25
Apotex Inc. Apo-Ranitidine Oral Solution 02280833 15 mg/mL All lots 2019-09-25
Apotex Inc. Apo-Ranitidine Tablet 150 mg 00733059 150 mg All lots 2019-09-25
Apotex Inc. Apo-Ranitidine Tablet 300 mg 00733067 300 mg All lots 2019-09-25
Pro Doc Limitée Ranitidine - 150 mg 00740748 150 mg All lots 2019-09-25
Pro Doc Limitée Ranitidine - 300 mg 00740756 300 mg All lots 2019-09-25
Sanis Health Inc. Ranitidine 02353016 150 mg All lots 2019-09-25
Sanis Health Inc. Ranitidine 02353024 300 mg All lots 2019-09-25
Sivem Pharmaceuticals ULC Ranitidine 02385953 150 mg NP4179
NP4183
NP4184
NP5656
NP5657
NT2721
NT2722
NT2724
NT2757
NT2762
NT2763
NT2764
NT2765
PJ2434
PJ2435
PV6243
PV6244
PV6245
2019-09-25
Sivem Pharmaceuticals ULC Ranitidine 02385961 300 mg NP4177
NP4180
NT1365
PX8854
2019-09-25
Sandoz Canada Sandoz Ranitidine 02243229 150 mg All lots 2019-09-17
Sandoz Canada Sandoz Ranitidine 02243230 300 mg All lots 2019-09-17

Communications related to ranitidine recalls:

Nizatidine recalls

If you're taking a recalled nizatidine product, you should:

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not impact Canadian products.

Some nizatidine products have been recalled due to the presence of nitrosamine impurities.

List of nizatidine drugs being recalled in Canada
Company Product Name DIN Strength Lot Expiry
Pendopharm Division of Pharmascience Inc. AXID 00778338 150mg 616927 31-08-2020
Pendopharm Division of Pharmascience Inc. AXID 00778338 150mg 617088 31-08-2020

Communications related to nizatidine recall:

Metformin recalls

Metformin

You should not stop taking your metformin drug without first discussing options with your health care provider. The risk of not having adequate diabetes treatment outweighs the risk from NDMA exposure.

Stopping metformin could lead to uncontrolled diabetes, which can cause some serious health problems.

For example, high blood sugars can result in:

Very high blood sugars can also cause:

Longer-term health impacts include heart disease, nerve problems, kidney damage, blindness and amputations.

Contact your health care provider:

Some metformin products have been recalled due to the presence of, or potential for, nitrosamine impurities.

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not impact Canadian products.

List of metformin drugs being recalled in Canada
Company Product name DIN Strength Lot Expiry
Apotex Inc. APO-Metformin ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500 mg NV3242 04/2020
Apotex Inc. APO-Metformin ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500 mg NV3244 04/2020
Apotex Inc. APO-Metformin ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500 mg NV3245 04/2020
Apotex Inc. APO-Metformin ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500 mg NV3243 04/2020
Apotex Inc. APO-Metformin ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500 mg NV3247 04/2020
Apotex Inc. APO-Metformin ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500 mg NV3248 04/2020
Apotex Inc. APO-Metformin ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500 mg PX5334 01/2021
Apotex Inc. APO-Metformin ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500 mg PX5335 01/2021
Ranbaxy Pharmaceuticals Canada Inc. RAN-Metformin 02269031 500 mg AJY8006A 05/2020
Ranbaxy Pharmaceuticals Canada Inc. RAN-Metformin 02269031 500 mg AJY8007A 05/2020
Ranbaxy Pharmaceuticals Canada Inc. RAN-Metformin 02269031 500 mg AJY8005A 05/2020
Ranbaxy Pharmaceuticals Canada Inc. RAN-Metformin 02269031 500 mg AJY8005B 05/2020
Ranbaxy Pharmaceuticals Canada Inc. RAN-Metformin 02269031 500 mg AJY8008A 05/2020
Ranbaxy Pharmaceuticals Canada Inc. RAN-Metformin 02269058 850 mg AJZ8005A 05/2020
JAMP Pharma Metformin 02380196 500 mg X20283 11/2020
JAMP Pharma Metformin 02380196 500 mg X20284 11/2020
JAMP Pharma Metformin 02380196 500 mg X20286 11/2020
JAMP Pharma Metformin 02380196 500 mg X20287 11/2020
JAMP Pharma Metformin 02380196 500 mg X20288 11/2020
JAMP Pharma Metformin 02380196 500 mg Y00225 12/2020
JAMP Pharma Metformin 02380196 500 mg Y00226 12/2020
JAMP Pharma Metformin 02380196 500 mg Y00227 12/2020
JAMP Pharma Metformin 02380196 500 mg Y00228 01/2021
JAMP Pharma Metformin 02380196 500 mg Y00229 01/2021
JAMP Pharma Metformin 02380196 500 mg Y00230 01/2021
JAMP Pharma Metformin 02380196 500 mg Y00231 05/2021
JAMP Pharma Metformin 02380196 500 mg Y00232 05/2021
JAMP Pharma Metformin 02380196 500 mg Y01573 05/2021
JAMP Pharma Metformin 02380196 500 mg Y01574 05/2021
JAMP Pharma Metformin 02380196 500 mg Y01575 05/2021
JAMP Pharma Metformin 02380196 500 mg Y01576 05/2021
JAMP Pharma Metformin 02380196 500 mg Y01577 05/2021
JAMP Pharma Metformin 02380196 500 mg Y01578 05/2021
JAMP Pharma Metformin 02380196 500 mg Y01579 06/2021
JAMP Pharma Metformin 02380196 500 mg Y01580 06/2021
JAMP Pharma Metformin 02380218 850 mg X20385 07/2020
JAMP Pharma Metformin 02380218 850 mg X20386 07/2020
JAMP Pharma Metformin 02380218 850 mg X19224 10/2020
JAMP Pharma Metformin 02380218 850 mg X19225 10/2020
JAMP Pharma Metformin 02380218 850 mg X19226 10/2020
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg PK3968 09/2020
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg PK3969 09/2020
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg PX5336 01/2021
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg PY7174 02/2021
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg PY7175 01/2021
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg RF6463 06/2021
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg RF6464 06/2021
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg RF6465 06/2021
Apotex Inc APO-METFORMIN ER (Metformin Hydrochloride Extended-Release Tablets) 02305062 500mg RF6466 06/2021

Communications related to metformin recalls:

Varenicline recalls

Varenicline

If you're taking a varenicline drug that has been recalled, you should:

Some varenicline products have been recalled due to the presence of, or potential for, nitrosamine impurities.

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not impact Canadian products. Recall is still outstanding for a single lot from Pfizer, please refer to the Dear Health Care Professional letter for more details.

List of varenicline drugs being recalled in Canada
Company Product name DIN Strength Lot Expiry
Teva Canada Ltd. TEVA-VARENICLINE TABLETS 02426226 0.5mg K60795 31/10/2021
Teva Canada Ltd. TEVA-VARENICLINE TABLETS 02426234 1mg K60783 30/4/2021
Teva Canada Ltd. TEVA-VARENICLINE TABLETS 02426234 1mg K60784 30/4/2021
Teva Canada Ltd. TEVA-VARENICLINE COMBO TABLETS 02426781 0.5mg/ 1mg K60796 30/4/2021
Pfizer Canada ULC CHAMPIX Tablet, Kit 02298309 0.5mg and 1mg 00019062 08/2021
Pfizer Canada ULC CHAMPIX Tablet, Kit 02298309 0.5mg and 1mg 00020452 12/2021
Pfizer Canada ULC CHAMPIX Tablet, Kit 02298309 0.5mg and 1mg 00020451 01/2022
Pfizer Canada ULC CHAMPIX Tablet 02291177 0.5mg ED7397 05/2022

Communications related to varenicline recalls:

Orphenadrine recalls

Orphenadrine

If you're taking an orphenadrine drug that has been recalled, you should:

Some orphenadrine products have been recalled due to the presence of or potential for nitrosamine impurities.

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not affect Canadian products.

List of orphenadrine drugs being recalled in Canada
Company Product name DIN Strength Lot Expiry
SteriMax Inc. OrfenAce tablets 02047535 100 mg 10025A18 06/2021
SteriMax Inc. OrfenAce tablets 02047535 100 mg 10025B18 09/2021
SteriMax Inc. OrfenAce tablets 02047535 100 mg 10025A19 11/2021
SteriMax Inc. OrfenAce tablets 02047535 100 mg 36664 6/2021
SteriMax Inc. OrfenAce tablets 02047535 100 mg 37342 9/2021
SteriMax Inc. OrfenAce tablets 02047535 100 mg 37384 9/2021
SteriMax Inc. OrfenAce tablets 02047535 100 mg 38058 11/2021
Sandoz Canada Inc. Sandoz Orphenadrine tablets 02243559 100 mg JY6254 3/2022
Sandoz Canada Inc. Sandoz Orphenadrine tablets 02243559 100 mg JY6255 3/2022

Communications related to orphenadrine recalls:

Amitriptyline recalls

Amitriptyline

If you're taking an amitriptyline drug that has been recalled, you should:

Some amitriptyline products have been recalled due to the presence of or potential for nitrosamine impurities.

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not affect Canadian products.

List of amitriptyline drugs being recalled in Canada
Company Product name DIN Strength Lot Expiry
Apotex Inc. APO-Amitriptyline tablets 02403137 10 mg RF0410 05/2024
Apotex Inc. APO-Amitriptyline tablets 02403137 10 mg PY1831 12/2023
Apotex Inc. APO-Amitriptyline tablets 02403137 10 mg PY1832 12/2023
AA Pharma Inc. ELAVIL tablets 00335053 10 mg PY1829 12/2023
AA Pharma Inc. ELAVIL tablets 00335053 10 mg PY1830 12/2023

Communications related to amitriptyline recalls:

Propranolol recalls

Propranolol

If you're taking a propranolol drug that has been recalled, you should:

Some propranolol products have been recalled due to the presence of or potential for nitrosamine impurities.

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not affect Canadian products.

List of propranolol drugs being recalled in Canada
Company Product name DIN Strength Lot Expiry
Pfizer Canada ULC Inderal-LA capsules 02042231 60 mg EX7461 01/2024
Pfizer Canada ULC Inderal-LA capsules 02042231 60 mg EH5907 08/2023
Pfizer Canada ULC Inderal-LA capsules 02042231 60 mg DX6150 03/2023
Pfizer Canada ULC Inderal-LA capsules 02042258 80 mg EX7462 01/2024
Pfizer Canada ULC Inderal-LA capsules 02042258 80 mg EL1695 08/2023
Pfizer Canada ULC Inderal-LA capsules 02042258 80 mg EE7221 05/2023
Pfizer Canada ULC Inderal-LA capsules 02042258 80 mg DW8242 03/2023
Pfizer Canada ULC Inderal-LA capsules 02042258 80 mg DJ2768 09/2023
Pfizer Canada ULC Inderal-LA capsules 02042266 120 mg FE0541 01/2024
Pfizer Canada ULC Inderal-LA capsules 02042266 120 mg EH5908 08/2023
Pfizer Canada ULC Inderal-LA capsules 02042266 120 mg DX6159 03/2023
Pfizer Canada ULC Inderal-LA capsules 02042266 120 mg DJ6820 09/2022
Pfizer Canada ULC Inderal-LA capsules 02042274 160 mg FE6304 01/2024
Pfizer Canada ULC Inderal-LA capsules 02042274 160 mg EH5906 08/2023
Pfizer Canada ULC Inderal-LA capsules 02042274 160 mg DW8241 03/2023

Communications related to propranolol recalls:

Quinapril recalls

Quinapril

If you're taking a quinapril drug that has been recalled, you should:

Some quinapril products have been recalled due to the presence of, or potential for, nitrosamine impurities.

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not affect Canadian products.

List of quinapril drugs being recalled in Canada
Company Product name DIN Strength Lot Expiry
Pfizer Canada ULC Accupril tablets 01947672 10 mg DY3042 03/2023
Pfizer Canada ULC Accupril tablets 01947672 10 mg CK5285 05/2022
Pfizer Canada ULC Accupril tablets 01947680 20 mg DT9592 03/2023
Pfizer Canada ULC Accupril tablets 01947680 20 mg CK6258 05/2022
Pfizer Canada ULC Accupril tablets 01947680 20 mg CK6259 05/2022
Pfizer Canada ULC Accupril tablets 01947699 40 mg DT9591 03/2023
Pfizer Canada ULC Accupril tablets 01947699 40 mg CM2828 05/2022
Pfizer Canada ULC Accupril tablets 01947699 40 mg CM2829 05/2022
Pfizer Canada ULC Accuretic tablets 02237367 10/12.5 mg FM9526 08/2023
Pfizer Canada ULC Accuretic tablets 02237367 10/12.5 mg FA3736 07/2022
Pfizer Canada ULC Accuretic tablets 02237367 10/12.5 mg EJ5192 07/2022
Pfizer Canada ULC Accuretic tablets 02237368 20/12,5 mg EX4411 07/2022
Pfizer Canada ULC Accuretic tablets 02237368 20/12,5 mg ET9511 07/2022
Pfizer Canada ULC Accuretic tablets 02237368 20/12,5 mg EF3087 07/2022
Pfizer Canada ULC Accuretic tablets 02237369 20/25 mg FA9224 07/2022
Pfizer Canada ULC Accuretic tablets 02237369 20/25 mg EA0781 07/2022

Communications related to quinapril recalls:

Acyclovir recalls

Acyclovir

If you're taking an acyclovir drug that has been recalled, you should:

Some acyclovir products have been recalled due to the presence of, or potential for, nitrosamine impurities.

Products not on this list have not been recalled in Canada. Recalls taking place in other countries may not affect Canadian products.

List of acyclovir drugs being recalled in Canada
Company Product Name DIN Strength Lot Expiry
Apotex Inc. Apo-Acyclovir 200 mg 02207621 200 mg RH9368 08/2022
Apotex Inc. Apo-Acyclovir 200 mg 02207621 200 mg RH9370 08/2022
Apotex Inc. Apo-Acyclovir 800 mg 02207656 800 mg RP8516 07/2022
Apotex Inc. Apo-Acyclovir 800 mg 02207656 800 mg RP8517 07/2022
Apotex Inc. Apo-Acyclovir 800 mg 02207656 800 mg RT8943 07/2022

Communications related to acyclovir recalls:

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: